Zagociguat
Based on 1 Customer Validation
Zagociguat (CY-6463) is an orally active and BBB-permeable soluble guanylate cyclase (sGC) stimulator. Zagociguat can increase cGMP levels, regulate blood pressure, improve neuronal function, reduce inflammatory responses, and exert neuroprotective and cognitive-improving effects. Zagociguat can be used in the research of neurodegenerative diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.09%
- CAS. Nr.: 2201048-82-8
- Formel: C16H10F4N6
- Molecular Weight:362.28
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
GPCR/G Protein Compound Library
HY-L006
-
Immunology/Inflammation Compound Library
HY-L007
-
Clinical Compound Library
HY-L026
-
CNS-Penetrant Compound Library
HY-L028
-
Drug Repurposing Compound Library
HY-L035
-
Differentiation Inducing Compound Library
HY-L038
-
Anti-Cardiovascular Disease Compound Library
HY-L046
-
Orally Active Compound Library
HY-L061
-
Neuroprotective Compound Library
HY-L070
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Angiogenesis-Related Compound Library
HY-L088
-
Cytokine Inhibitors Library
HY-L161
-
Radioprotector Library
HY-L178
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Drug Repurposing Compound Library Plus
HY-L035P
-
Clinical Compound Library Plus
HY-L026P
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
-
Lactylation Compound Library
HY-L249
Biologische Aktivität
Soluble Guanylate Cyclase[1]
Zagociguat (0.01 nM-30 μM; 20-30 min) can effectively stimulate sGC (EC50: 46 nM) and CREB phosphorylation (EC50: 25.7 nM) in rat primary neurons[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Zagociguat (7-308 nM; perfusion; single dose) increases long-term potentiation in hippocampal slices of a Huntington's disease mouse model[1].
Zagociguat (0.5-10 mg/kg; dietary administration; 6 weeks) can reduce the levels of plasma inflammatory markers TNFα and IL-16 and increase BDNF levels in the hindbrain and hypothalamus in diet-induced obese male mice[1].
Zagociguat (71.6 mg/kg; dietary administration; 18 weeks) can reduce the loss of dendritic spines in the hippocampus of aged male mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 2201048-82-8
-
Appearance Solid
-
Molecular Weight 362.28
-
Formel C16H10F4N6
-
Color Off-white to light yellow
-
SMILES
FC1=C(CC2=NC(C3=NN=C(C(F)(F)F)N3)=CN4C=CN=C24)C=CC=C1
-
Synonyms
CY-6463; IW-6463
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Lösungsmittel & Löslichkeit
DMSO : 250 mg/mL (690.07 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Reinheit & Dokumentation
-
Data Sheet (277 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7603 mL | 13.8015 mL | 27.6030 mL | 69.0074 mL |
| 5 mM | 0.5521 mL | 2.7603 mL | 5.5206 mL | 13.8015 mL | |
| 10 mM | 0.2760 mL | 1.3801 mL | 2.7603 mL | 6.9007 mL | |
| 15 mM | 0.1840 mL | 0.9201 mL | 1.8402 mL | 4.6005 mL | |
| 20 mM | 0.1380 mL | 0.6901 mL | 1.3801 mL | 3.4504 mL | |
| 25 mM | 0.1104 mL | 0.5521 mL | 1.1041 mL | 2.7603 mL | |
| 30 mM | 0.0920 mL | 0.4600 mL | 0.9201 mL | 2.3002 mL | |
| 40 mM | 0.0690 mL | 0.3450 mL | 0.6901 mL | 1.7252 mL | |
| 50 mM | 0.0552 mL | 0.2760 mL | 0.5521 mL | 1.3801 mL | |
| 60 mM | 0.0460 mL | 0.2300 mL | 0.4600 mL | 1.1501 mL | |
| 80 mM | 0.0345 mL | 0.1725 mL | 0.3450 mL | 0.8626 mL | |
| 100 mM | 0.0276 mL | 0.1380 mL | 0.2760 mL | 0.6901 mL |
Zagociguat Related Classifications
HY-145607 Related Classifications
Powered by Bioz